<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6063440</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0201233</article-id><article-id pub-id-type="publisher-id">PONE-D-18-13906</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject><subj-group><subject>Oils</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Blood Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>T Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>T Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>T Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>T Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Alternaria</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Alternaria</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Mycology</subject><subj-group><subject>Fungal Pathogens</subject><subj-group><subject>Alternaria</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune Physiology</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System</subject><subj-group><subject>Innate Immune System</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System</subject><subj-group><subject>Innate Immune System</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Developmental Biology</subject><subj-group><subject>Molecular Development</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Response</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmaceutics</subject><subj-group><subject>Pharmaceutical Processing Technology</subject><subj-group><subject>Drug Delivery System Preparation</subject><subj-group><subject>Microencapsulation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>Antigen-Presenting Cells</subject><subj-group><subject>Dendritic Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>Antigen-Presenting Cells</subject><subj-group><subject>Dendritic Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>Antigen-Presenting Cells</subject><subj-group><subject>Dendritic Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Effect of microencapsulated essential oil form <italic>Chamaecyparis obtusa</italic> on monocyte-derived dendritic cell activation and CD4<sup>+</sup> T cell polarization</article-title><alt-title alt-title-type="running-head">Immune-modulatory effect of <italic>Chamaecyparis obtusa</italic> essential oil</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9118-0590</contrib-id><name><surname>Shin</surname><given-names>Seung-Heon</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="corresp" rid="cor001">*</xref><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Mi-Kyung</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Validation</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Dong-Won</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Che</surname><given-names>Mi-Hyun</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><xref ref-type="aff" rid="aff001"/></contrib></contrib-group><aff id="aff001"><addr-line>Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Catholic University of Daegu, Daegu, South Korea</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Mishra</surname><given-names>Amarjit</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Auburn University College of Veterinary Medicine, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>hsseung@cu.ac.kr</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><issue>7</issue><elocation-id>e0201233</elocation-id><history><date date-type="received"><day>10</day><month>5</month><year>2018</year></date><date date-type="accepted"><day>11</day><month>7</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Shin et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Shin et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0201233.pdf"/><abstract><p>The essential oil of <italic>Chamaecyparis obtusa</italic> (<italic>C</italic>. <italic>obtusa</italic>), which is used in soap, toothpaste, and aromatic agents, has been known to have anti-inflammatory properties. In this study, we investigated the effects of microencapsulated <italic>C</italic>. <italic>obtusa</italic> essential oil on airborne fungus-induced dendritic cell (DC) activation and Th immune responses. We stimulated monocyte-derived DCs with <italic>Alternaria</italic> alternate and lipopolysaccharide (LPS). To determine the anti-inflammatory effects, we pre-treated DCs with various concentrations of microencapsulated <italic>C</italic>. <italic>obtusa</italic> essential oil and collected the supernatants to measure interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-&#x003b1;), and we determined the expression of cell surface molecules. The effects of the essential oil on CD4<sup>+</sup> T cells polarization was determine by culturing stimulated DCs and autologous CD4<sup>+</sup> T cells. <italic>Alternaria</italic> enhanced the production of IL-6 and TNF-&#x003b1; from DCs, and pretreating DCs with 0.001, 0.01, and 0.05% of the essential oil significantly inhibited their production. Increased CD80 and CD86 expression by <italic>Alternaria</italic> was significantly inhibited with 0.05% of the essential oil. <italic>Alternaria</italic>-induced IL-5, IL-10, and interferon-gamma from CD4<sup>+</sup> T cells were significantly inhibited with <italic>C</italic>. <italic>obtusa</italic> essential oil in a dose dependent manner. <italic>C</italic>. <italic>obtusa</italic> influenced both <italic>Alternaria</italic>- and LPS-induced Th1 and Th2 polarization of CD4<sup>+</sup> T cells. These results suggest a novel pharmacological use for <italic>C</italic>. <italic>obtusa</italic> essential oil to treat inflammatory airway diseases.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>Basic Science Research Program through the National Research Foundation of Korea</institution></funding-source><award-id>2016R1D1A1B03931622</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9118-0590</contrib-id><name><surname>Shin</surname><given-names>Seung-Heon</given-names></name></principal-award-recipient></award-group><funding-statement>This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A1B03931622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="1"/><page-count count="9"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>Data are available from figshare (DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.6728396">10.6084/m9.figshare.6728396</ext-link>). All other relevant data are within the paper.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>Data are available from figshare (DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.6728396">10.6084/m9.figshare.6728396</ext-link>). All other relevant data are within the paper.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>A number of environmental factors are associated with allergic airway disease. House dust mites and mold are significant airborne allergens for developing allergic rhinitis and asthma. Most fungi are ubiquitous in the environment, and they enter the respiratory tract by means of inhalation. Among several pathogenic fungi, <italic>Alternaria</italic> and <italic>Aspergillus</italic> are commonly found in the airway and trigger airway diseases. [<xref rid="pone.0201233.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0201233.ref002" ref-type="bibr">2</xref>] Severe life-threating asthma and eosinophilic airway inflammation have been associated increased airborne exposure to <italic>Alternaria</italic>. [<xref rid="pone.0201233.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0201233.ref004" ref-type="bibr">4</xref>] Fungi contain several immunologic factors that are potent regulators of the host immune response. These immunologic factors, with pathogen-associated molecular patterns, interact with pattern recognition receptors in antigen-presenting cells. [<xref rid="pone.0201233.ref005" ref-type="bibr">5</xref>] Multiple fungal signaling pathways in these cells affect the local Th cell balance. For example, inflammatory dendritic cells (DCs) initiate antifungal response in the Th17 and Th2 signaling pathways, and tolerogenic DCs activate Th1 and Treg cell immune response. [<xref rid="pone.0201233.ref002" ref-type="bibr">2</xref>] <italic>Alternaria</italic> can develop Th2-type immune response in the airway by activating dendritic cells. [<xref rid="pone.0201233.ref001" ref-type="bibr">1</xref>]</p><p>Phytotherapy is alternative medicine that uses extracts from natural products that are known to promote health with varying benefits and lack of side effects. [<xref rid="pone.0201233.ref006" ref-type="bibr">6</xref>] Essential oils from trees and plants have protective mechanisms against harmful insects and microorganisms, and a number of essential oils have shown anti-bacterial, anti-fungal, anti-oxidative, and anti-inflammatory activity. [<xref rid="pone.0201233.ref007" ref-type="bibr">7</xref>&#x02013;<xref rid="pone.0201233.ref009" ref-type="bibr">9</xref>] <italic>Chamaecyparis obtusa</italic> (<italic>C</italic>. <italic>obtusa</italic>) is a tropical tree species found in the southern part of South Korea. The essential oil of <italic>C</italic>. <italic>obtusa</italic> contains several monoterpene hydrocarbons, oxygenated monoterpenes, sesquiterpene hydrocarbons, oxygenated sesquiterpenes, and others. [<xref rid="pone.0201233.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0201233.ref011" ref-type="bibr">11</xref>] The essential oil of <italic>C</italic>. <italic>obtusa</italic> has been applied in soap, toothpaste, and aromatic agents with anti-oxidative and anti-inflammatory effects. [<xref rid="pone.0201233.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0201233.ref012" ref-type="bibr">12</xref>] <italic>C</italic>. <italic>obtusa</italic> has been demonstrated to reduce the production of prostaglandin (PG) E2, tumor necrosis factor-&#x003b1; (TNF-&#x003b1;), interleukine-6 (IL-6), and cyclooxygenase-2 (COX-2) in peripheral blood mononuclear cells in a murine model of inflammation. [<xref rid="pone.0201233.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0201233.ref013" ref-type="bibr">13</xref>]</p><p>Although the biological activities of C. obtuse essential oil are not fully understand, antimicrobial, anti-fungal, and anti-nociceptive effects have been studied. [<xref rid="pone.0201233.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0201233.ref010" ref-type="bibr">10</xref>] However, the anti-inflammatory or immune modulatory effect of C. obtuse essential oil on airway mucosa is not commonly studied. In the present study, we investigated the anti-inflammatory effects and the influence on Th cell polarization of <italic>C</italic>. <italic>obtusa</italic> essential oil in airborne fungi and Gram-negative bacteria induced monocyte-derived DC activation and Th immune responses by determining the expression of inflammatory chemical mediators and Th cytokines.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>Preparation of the C. <italic>obtusa</italic> essential oil</title><p>Qwell Inc. (Seoul, South Korea) kindly presented Microencapsulated <italic>C</italic>. <italic>obtusa</italic> essential oil; it was isolated from leaves collected in Masan, Kyunsangnamdo, South Korea. The leaves dried under shade, and using the seam distillation and extraction methods, they extracted essential oil from the leaves. The collected essential oil was stored at room temperature for one year to stabilize its components. The chemical composition of <italic>C</italic>. <italic>obtusa</italic> essential oil was determined using a gas chromatography mass spectrometry analysis (Agilent Tech., Santa Clara, CA, USA). Essential oil contained more than 20 components and the main chemical composition of <italic>C</italic>. <italic>obtusa</italic> essential oil is in <xref rid="pone.0201233.t001" ref-type="table">Table 1</xref>. For microencapsulation, they emulsified the oil by mixing it with a water-soluble stylene maleic anhydride polymer in water and then adding melanin pre-condensate to the mixture, resulting in the formation of microcapsules consisting of a spherical inner core and an outer shell surrounding the inner core.</p><table-wrap id="pone.0201233.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0201233.t001</object-id><label>Table 1</label><caption><title>Main components of essential oil from <italic>Chamaecyparis obtusa</italic>.</title></caption><alternatives><graphic id="pone.0201233.t001g" xlink:href="pone.0201233.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">Compound</th><th align="justify" rowspan="1" colspan="1">Retention time (min)</th><th align="justify" rowspan="1" colspan="1">Peak area (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#x003b1;-Pinene</td><td align="left" rowspan="1" colspan="1">8.75</td><td align="left" rowspan="1" colspan="1">5.96</td></tr><tr><td align="left" rowspan="1" colspan="1">Sabinene</td><td align="left" rowspan="1" colspan="1">10.96</td><td align="left" rowspan="1" colspan="1">16.72</td></tr><tr><td align="left" rowspan="1" colspan="1">Myrcene</td><td align="left" rowspan="1" colspan="1">11.36</td><td align="left" rowspan="1" colspan="1">19.45</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b1;-Terpinene</td><td align="left" rowspan="1" colspan="1">12.69</td><td align="left" rowspan="1" colspan="1">3.05</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b3;-Terpinene</td><td align="left" rowspan="1" colspan="1">13.54</td><td align="left" rowspan="1" colspan="1">4.75</td></tr><tr><td align="left" rowspan="1" colspan="1">Limonene</td><td align="left" rowspan="1" colspan="1">13.76</td><td align="left" rowspan="1" colspan="1">1.82</td></tr><tr><td align="left" rowspan="1" colspan="1">Terepineol</td><td align="left" rowspan="1" colspan="1">15.21</td><td align="left" rowspan="1" colspan="1">1.26</td></tr><tr><td align="left" rowspan="1" colspan="1">Terpinene-4-ol</td><td align="left" rowspan="1" colspan="1">16.23</td><td align="left" rowspan="1" colspan="1">2.82</td></tr><tr><td align="left" rowspan="1" colspan="1">Bornyl acetate</td><td align="left" rowspan="1" colspan="1">27.53</td><td align="left" rowspan="1" colspan="1">9.46</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b1; -Terpinyl acetate</td><td align="left" rowspan="1" colspan="1">28.64</td><td align="left" rowspan="1" colspan="1">15.69</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec004"><title>Generation of the monocyte-derived DCs</title><p>We isolated peripheral blood mononuclear cells (PBMCs) from normal healthy volunteers after they provided informed consent. The procedure was approved by the Institutional Review Board of Daegu Catholic University Medical Center. A duly completed written informed consent form that outlined the objectives of the research and experiments was obtained from each subject. The cells were isolated by density gradient centrifugation on Histopaque (Sigma-Aldrich, St. Louis, MO, USA). We harvested cells from the interphase and washed them with phosphate-buffered solution, and then we mixed the PBMCs with anti-CD14 antibody conjugated with magnetic particles (Miltenyl Biotec, Sunnyvale, CA, USA) at 4&#x000b0;C for 30 minutes to obtain monocytes. We cultured the positively collected cells with 25 ng/ml of granulocyte-macrophage colony-stimulating factor and 10 ng/ml of interleukin-4 (IL-4; R&#x00026;D Systems, Minneapolis, MN, USA). After 6 days of culture, we harvested the DC-enriched portion and analyzed as previously reported. [<xref rid="pone.0201233.ref014" ref-type="bibr">14</xref>] Cells differentiation and purity were determined with flow cytometry (Becton Dickinson, Mountain View, CA, USA). We used cells preparation contained more than 90% of DC phenotype CD11c.</p></sec><sec id="sec005"><title>Cyotoxicity of <italic>C</italic>. <italic>obtusa</italic> essential oil</title><p>We determined the cellular cytotoxicity of the microencapsulated essential oil with monocyte-derived DCs and CD4<sup>+</sup> T cells. Cells were plated into the wells of 96-well tissue culture plates (DCs at 1 &#x000d7; 10<sup>6</sup>/mL, CD4<sup>+</sup> T cells at 2 &#x000d7; 10<sup>6</sup>/mL,) and cultured in the presence of 0.05 to 1% of essential oil (DCs for 24 hours, CD4<sup>+</sup> T cells for 72 hours) at 37&#x000b0;C in a humidified 5% CO2 chamber. We measured cytotoxicity using a CellTiter-96<sup>&#x000ae;</sup> aqueous cell proliferation assay kit (Promega, Madison, WI, USA). The tetrazolium compound and Owen&#x02019;s reagent were added to each well and incubated the plate for 4 hours, and the color intensities were assessed with a microplate reader at 490 nm wavelength (Molecular Devices, Sunnyvale, CA, USA).</p></sec><sec id="sec006"><title><italic>C</italic>. <italic>obtusa</italic> essential oil inhibition of DC activation</title><p>To investigate the anti-inflammatory effects of <italic>C</italic>. <italic>obtusa</italic> essential oil, we suspended 1 &#x000d7; 10<sup>6</sup>/mL of the monocyte-derived DCs in RPMI-1640 with 10% fetal bovine serum and pretreated them with various concentrations of the essential oil for 1 hour and then stimulated the mixture with 50 ug/ml of endotoxin-removed <italic>Alternaria alternata</italic> (Greer Lab., Lenoir, NC, USA) or 1 ug/ml of lipopolysaccharide (LPS; Sigma-Aldrich) for 6 hours.</p><p>We assessed the effect of <italic>C</italic>. <italic>obtusa</italic> essential oil on the production of cytokines in DCs to <italic>Alternaria</italic> and LPS stimulation with ELISA and the expression of cell surface molecules with fluorescence-activated cell sorting (FACS). For cytokine analysis, we analyzed cell-free supernatants for IL-6 and TNF-&#x003b1; with a commercially available ELISA assay kit (R&#x00026;D Systems). For FACS analysis, the DCs were stained with PE-conjugated anti-CD11c and FITC-conjugated anti-CD 80, anti-CD 86, and anti-HLA-DR and with corresponding isotype-matched control monoclonal antibodies. We obtained all antibodies used for FACS analysis from Becton Dickinson and conducted the analysis with a FACScan flow cytometer (Becton Dickinson). We expressed the mean fluorescence intensities of costimulatory molecules as a percentage of treated versus non-treated cells.</p></sec><sec id="sec007"><title>Effects of <italic>C</italic>. <italic>obtusa</italic> essential oil on DCs and CD4<sup>+</sup> T cell coculture</title><p>We measured the effects of the essential oil on CD4<sup>+</sup> T cells polarization based on cytokine production by culturing monocyte-derived DCs and autologous CD4<sup>+</sup> T cells. We isolated the CD4<sup>+</sup> T cells by treating the PBMCs with anti-CD4 antibody conjugated with magnetic particles (Miltenyl Biotec). We cultured CD4<sup>+</sup> T cells at a ratio of 10:1 with stimulated DCs pulsed with <italic>Alternaria</italic> or LPS for 72 hours. We measured the cytokine production in the cell-free supernatant for IL-5, IL-10, and interferon-gamma (INF-&#x003b3;; R&#x00026;D systems).</p></sec><sec id="sec008"><title>Statistics</title><p>The results are expressed as mean &#x000b1; standard error of mean and reflect six independent experiments. We performed one-way analysis of variance followed by Tukey&#x02019;s test for normally distributed data and the Kruskal-Wallis tests with post-hoc Bonferroni-Dunn testing for non-normally distributed data (SPSS Inc., Chicago, IL, USA) and considered <italic>p</italic> less than 0.05 statistically significant.</p></sec></sec><sec sec-type="results" id="sec009"><title>Results</title><sec id="sec010"><title>Cytotoxicity of <italic>C</italic>. <italic>obtusa</italic> essential oil</title><p>In order to determine the optimal concentration of essential oil, we treated DCs and the CD4<sup>+</sup> T cells for 24 and 72 hours with different concentration of the essential oil. The DCs&#x02019; viability decreased significantly with an oil concentration of 0.1% (82.3 &#x000b1; 7.9 after 6 hours and 67.3 &#x000b1; 6.4 after 24 hours). The exposure time did not influence the DCs&#x02019; survival. When the CD4<sup>+</sup> T cells were treated with 0.05, 0.2, 0.5, and 1% of essential oil for 24, 48, and 72 hours, CD4<sup>+</sup> T cells survival decreased significantly with 0.5% and 1% of the oil, and again the exposure time did not influence cell viability (<xref ref-type="fig" rid="pone.0201233.g001">Fig 1</xref>).</p><fig id="pone.0201233.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0201233.g001</object-id><label>Fig 1</label><caption><title>Effects of <italic>C</italic>. <italic>obtusa</italic> essential oil on survival of dendritic cells (DCs) and peripheral blood mononuclear cells (PBMCs).</title><p>DC survival decreased significantly with 0.1% of the essential oil (A), and PBMC survival decreased significantly at concentration exceeding 0.5% (B). Exposure time did not influence cell survival. NT: not treated with essential oil, H: hours, * p&#x0003c;0.05.</p></caption><graphic xlink:href="pone.0201233.g001"/></fig></sec><sec id="sec011"><title>Inhibition of DCs activation with <italic>C</italic>. <italic>obtusa</italic> essential oil</title><p>We pretreated the DCs with the essential oil for 1 hour, and then stimulated them with <italic>Alternaria</italic> or LPS for 6 hours. DCs had been reported to produce IL-6 and TNF-&#x003b1;, and these cytokines play important roles in regulating T cell differentiation and inflammation. <italic>Alternaria</italic> and LPS significantly increased the production of IL-6 (<italic>Alternaria</italic>: 410.9 &#x000b1; 52.7 pg/ml, LPS: 711.6 &#x000b1; 122.3 pg/ml) and TNF-&#x003b1; (<italic>Alternaria</italic>: 1007.2 &#x000b1; 253.7 pg/ml, LPS: 2837.6 &#x000b1; 357.2 pg/ml) compared with the untreated group (IL-6: 255.6 &#x000b1; 43.6 pg/ml, TNF-&#x003b1;: 752.6 &#x000b1; 176.6 pg/ml; p &#x0003c; 0.05). When the DCs were pretreated with 0.001, 0.01, and 0.05% of the oil, <italic>Alternaria</italic> induced IL-6 and TNF-&#x003b1; productions were significantly inhibited. However, the <italic>C</italic>. <italic>obtusa</italic> essential oil did not suppress either LPS-induced IL-6 or TNF-&#x003b1; productions (<xref ref-type="fig" rid="pone.0201233.g002">Fig 2</xref>).</p><fig id="pone.0201233.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0201233.g002</object-id><label>Fig 2</label><caption><title>Effects of <italic>C</italic>. <italic>obtusa</italic> essential oil on chemical mediator production from dendritic cells (DCs).</title><p>When DCs were pretreated with various concentrations (0.001&#x02013;0.05%) of <italic>C</italic>. <italic>obtusa</italic>, interleukin-6 (IL-6) and tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) induced by <italic>Alternaria</italic> 50 ug/ml (Alt 50) was significantly inhibited. However, chemical mediator production induced by lipopolysaccharide 1 ug/ml (LPS 1) was not inhibited. NT: not treated with essential oil, * p &#x0003c; 0.05 vs. NC, &#x00197;: p &#x0003c; 0.05 vs. Alt 50 or LPS 1.</p></caption><graphic xlink:href="pone.0201233.g002"/></fig><p>When the DCs were incubated for 6 hours with <italic>Alternaria</italic>, the expression of costimulatory molecules including CD80, CD86, and HLA-DR was increased. LPS also increased the expression of CD80 and HLA-DR but not CD86 in DCs. Increased CD80 and CD86 expression by <italic>Alternaria</italic> was significantly inhibited with 0.05% of the essential oil, but the oil did not influence HLA-DR expression in the DCs. The <italic>C</italic>. <italic>obtusa</italic> essential oil did not influence the LPS induced CD80, CD86, and HLA-DR expression (<xref ref-type="fig" rid="pone.0201233.g003">Fig 3</xref>).</p><fig id="pone.0201233.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0201233.g003</object-id><label>Fig 3</label><caption><title>Effects of <italic>C</italic>. <italic>obtusa</italic> essential oil on expression of co-stimulatory molecules by dendritic cells (DCs) and chemical mediator production from DCs.</title><p><italic>Alternaria</italic> 50 ug/ml (Alt 50) and lipopolysaccharide 1 ug/ml (LPS 1) significantly enhanced CD80, CD86, and HLA-DR expression, but 0.05% of the essential oil (EO0.05) only inhibited the expression of CD80 and CD86. (A) Representative flow cytometric histograms show expression of costimulatory molecules incubated with <italic>Alternaria</italic> alone or with EO0.005 pretreatment. (B) Mean fluorescence intensity (MFI) levels are shown from five independent experiments. NT: not treated with essential oil, * p &#x0003c; 0.05 vs. NC, &#x00197;: p &#x0003c; 0.05 vs. Alt 50 or LPS 1.</p></caption><graphic xlink:href="pone.0201233.g003"/></fig></sec><sec id="sec012"><title>Regulation of CD4<sup>+</sup> T cell polarization and IL-5, IL-10, and INF-&#x003b3; production with <italic>C</italic>. <italic>obtusa</italic> essential oil</title><p>We purified autologous CD4<sup>+</sup> T cells to coculture them with the DCs. To determine the effects of the essential oil from <italic>C obtusa</italic>, we pretreated the DCs with the oil for 1 hour and stimulated with <italic>Alternaria</italic> or LPS for 24 hours, then we cocultured the DCs with CD4<sup>+</sup> T cells for 72 hours. <italic>Alternaria</italic> and LPS enhanced the production of IL-5, IL-10, and INF-&#x003b3; from the CD4<sup>+</sup> T cells. <italic>Alternaria</italic>-induced cytokine production was significantly inhibited with the <italic>C</italic>. <italic>obtusa</italic> essential oil in a dose-dependent manner. LPS-induced INF-&#x003b3; production was significantly inhibited with the essential oil, but the oil did not inhibit LPS-induced IL-10 production from CD4<sup>+</sup> T cells (<xref ref-type="fig" rid="pone.0201233.g004">Fig 4</xref>).</p><fig id="pone.0201233.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0201233.g004</object-id><label>Fig 4</label><caption><title>Effects of <italic>C</italic>. <italic>obtusa</italic> essential oil on dendritic cells (DCs) stimulated with <italic>Alternaria</italic> 50 ug/ml (Alt 50) and lipopolysaccharide 1 ug/ml (LPS 1) induced distinctive cytokines from autologous CD4<sup>+</sup> T cells.</title><p><italic>Alternaria</italic>-induced interleukin-5 (IL-5), interferon gamma (INF-&#x003b3;), and IL-10 production and LPS-induced INF-&#x003b3; production were significantly inhibited with various concentrations (0.001&#x02013;0.01%) of <italic>C</italic>. <italic>obtusa</italic>. NT: not treated with essential oil, * p &#x0003c; 0.05 vs. NC, &#x00197;: p &#x0003c; 0.05 vs. Alt 50 or LPS 1.</p></caption><graphic xlink:href="pone.0201233.g004"/></fig></sec></sec><sec sec-type="conclusions" id="sec013"><title>Discussion</title><p>Essential oils acquired in nature and contain various components with medical properties such as antibacterial, antiviral, antioxidant and other immunologic effects. [<xref rid="pone.0201233.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0201233.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0201233.ref016" ref-type="bibr">16</xref>] Because essential oils are volatile, microencapsulation of essential oils can protect the active compounds against environmental factors such as oxygen, light, and moisture. This microcapsulation also protects the oil from degradation or evaporation and increases their solubility in water. [<xref rid="pone.0201233.ref017" ref-type="bibr">17</xref>] C. obtusa plain oil was about 10 times toxic to respiratory epithelial cells and peripheral blood mononuclear cells than microencapsulated oil. (data not shown) The plain oil compounds might be more volatile and active than microencapsulated one. Stylene maleic anhydride polymer is a synthetic polymer and it has been used as a sealer coat prior to modified release coating and food packing material listed by FDA. [<xref rid="pone.0201233.ref018" ref-type="bibr">18</xref>] It can form a microcapsule by interfacial polycondensation or complex coacervation. <italic>C</italic>. <italic>obtusa</italic> is used for furniture and in cosmetics due to its structural characteristics, natural scent, and anti-inflammatory properties. [<xref rid="pone.0201233.ref012" ref-type="bibr">12</xref>] The essential oil from <italic>C</italic>. <italic>obtusa</italic> contains several monoterpenes that can be promising candidates for new pharmacologic agents. [<xref rid="pone.0201233.ref019" ref-type="bibr">19</xref>] <italic>C</italic>. <italic>obtusa</italic> inhibit the production of nitric oxide and prostaglandin, and the expression of inducible nitric oxide synthase, cyclooxygenase-2, and nuclear factor-kappa B in inflammatory cells. [<xref rid="pone.0201233.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0201233.ref020" ref-type="bibr">20</xref>] However, the immunologic function of the essential oil of <italic>C</italic>. <italic>obtusa</italic> is not commonly studied. Therefore, in the present study, we analyzed the oil&#x02019;s effects on Th cell polarization. We demonstrated that the essential oil from <italic>C</italic>. <italic>obtusa</italic> had an anti-inflammatory effect, inhibiting both Th1 and Th2 cytokine production from CD4<sup>+</sup> T cells. In addition, <italic>C</italic>. <italic>obtusa</italic> inhibited the production of proinflammatory cytokines and costimulatory molecules of DCs.</p><p>DCs are one of the key cellular components of immune regulation and determine T cell responses. [<xref rid="pone.0201233.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0201233.ref021" ref-type="bibr">21</xref>] Chemical mediators secreted from DCs cause differentiation of CD4<sup>+</sup> T cells into Th1, Th2, or other Th cells, which drives adaptive immune responses. [<xref rid="pone.0201233.ref021" ref-type="bibr">21</xref>] In this study, we attempted to evaluate the effects of <italic>C</italic>. <italic>obtusa</italic> on T cell immune responses. Because DCs are key regulatory cell for T cell polarization, we treated the cells with the essential oil of <italic>C</italic>. <italic>obtusa</italic> rather than directly treating CD4<sup>+</sup> T cells. <italic>Alternaria</italic>-induced proinflammatory cytokine production and the expression of costimulatory molecules including CD80 and CD86 were significantly suppressed with <italic>C</italic>. <italic>obtusa</italic>.</p><p>LPS has been known to activate macrophage and promote of Th1 immune response. [<xref rid="pone.0201233.ref022" ref-type="bibr">22</xref>] LPS strongly induced proinflammatory cytokine production in DCs and Th1 cells, and regulate the polarization of CD4<sup>+</sup> T cells. <italic>Alternaria</italic>, commonly found and associated with upper and lower airway diseases, activates DCs and induces Th2-type cytokine production. [<xref rid="pone.0201233.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0201233.ref023" ref-type="bibr">23</xref>] Activation of DCs with <italic>Alternaria</italic> induced Th1, Th2, and Th10 immune responses, particulary of the Th2 cytokine IL-5 (by approximately 5 times compared with negative control). Although we attempted to remove endotoxins from <italic>Alternaria</italic> extracts, the <italic>Alternaria</italic> preparation contained some endotoxin activity (3.7 EU/mg), and the IL-10 and INF-&#x003b3; production could have been influenced by the endotoxin components in the <italic>Alternaria</italic> preparation. <italic>C</italic>. <italic>obtusa</italic> essential oil suppressed Th1, Th2, and Th10 cytokines in CD4<sup>+</sup> T cells. Among three cytokines, IL-5 production was most strongly suppressed (IL-5: 75%, INF-&#x003b3;: 41%, and IL-10: 44%). These results indicate that the essential oil of <italic>C</italic>. <italic>obtusa</italic> can strongly suppress <italic>Alternaria</italic>-induced Th2 immune responses. Inhibition of <italic>Alternaria</italic>-induced IL-6 production from with <italic>C</italic>. <italic>obtusa</italic> may influence the inhibition of Th2 immune response. IL-6 produced from DCs can suppress Th1 polarization and directly induce Th2 differentiation of na&#x000ef;ve T cells. [<xref rid="pone.0201233.ref024" ref-type="bibr">24</xref>] However, <italic>C</italic>. <italic>obtusa</italic> did not significantly affect LPS-induced DC activation and LPS-treated DCs enhanced the Th1 cytokine production in CD4<sup>+</sup> T cells, which means that <italic>C</italic>. <italic>obtusa</italic> essential oil can influence both Th1 and Th2 immune responses. Because we did not evaluate any immunoregulatory properties of <italic>C</italic>. <italic>obtusa</italic>, additional studies are necessary to determine whether down-regulation of IL-6 is sufficient to inhibit Th2 polarization of CD4<sup>+</sup> T cells or ILS-induced Th1 polarization.</p></sec><sec sec-type="conclusions" id="sec014"><title>Conclusion</title><p>The principal finding of this study is the Th1 and Th2 immunomodulatory properties of <italic>C</italic>. <italic>obtusa</italic> essential oil. <italic>Alternaria</italic> and LPS can induce production of chemical mediators in monocyte-derived DCs and <italic>C</italic>. <italic>obtusa</italic> influenced both <italic>Alternaria</italic>- and LPS-induced Th1 and Th2 polarization of CD4<sup>+</sup> T cells. However, only IL-6 and TNF-&#x003b1; production induced by <italic>Alternaria</italic> was inhibited with <italic>C</italic>. <italic>obtusa</italic>. Because the <italic>C</italic>. <italic>obtusa</italic> essential oil influenced both <italic>Alternaria</italic>-induced DC activation and Th2 polarization, <italic>C</italic>. <italic>obtusa</italic> may more strongly inhibit Th2 immune response. These results suggest a novel pharmacological use of <italic>C</italic>. <italic>obtusa</italic> essential oil for treating fungus-induced Th2 inflammatory airway diseases. We need further study to confirm the inhibitory properties of <italic>C</italic>. <italic>obtusa</italic> essential oil in Th2 immune response with other airborne allergens and its possible anti-allergic effects with allergic animal models.</p></sec></body><back><ack><p>The authors wish to thank Jae-Won Jang (Qwell Inc., Seoul, South Korea) for providing microencapsulated essential oil for this study.</p></ack><ref-list><title>References</title><ref id="pone.0201233.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Kobayashi</surname><given-names>T</given-names></name>, <name><surname>Iijima</surname><given-names>K</given-names></name>, <name><surname>Radhakrishnan</surname><given-names>S</given-names></name>, <name><surname>Mehta</surname><given-names>V</given-names></name>, <name><surname>Vassallo</surname><given-names>R</given-names></name>, <name><surname>Lawrence</surname><given-names>CB</given-names></name>, <etal>et al</etal>
<article-title>Asthma-related environmental fungus, Alternaria, activates dendritic cells and produces potent Th2 adjuvant activity</article-title>. <source>Journal of immunology (Baltimore, Md: 1950)</source>. <year>2009</year>;<volume>182</volume>(<issue>4</issue>):<fpage>2502</fpage>&#x02013;<lpage>10</lpage>. Epub 2009/02/10. <pub-id pub-id-type="doi">10.4049/jimmunol.0802773</pub-id> ; PubMed Central PMCID: PMCPMC2653279.<?supplied-pmid 19201906?><pub-id pub-id-type="pmid">19201906</pub-id></mixed-citation></ref><ref id="pone.0201233.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Romani</surname><given-names>L</given-names></name>. <article-title>Immunity to fungal infections</article-title>. <source>Nat Rev Immunol</source>. <year>2011</year>;<volume>11</volume>(<issue>4</issue>):<fpage>275</fpage>&#x02013;<lpage>88</lpage>. Epub 2011/03/12. <pub-id pub-id-type="doi">10.1038/nri2939</pub-id> .<?supplied-pmid 21394104?><pub-id pub-id-type="pmid">21394104</pub-id></mixed-citation></ref><ref id="pone.0201233.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Agarwal</surname><given-names>R</given-names></name>, <name><surname>Gupta</surname><given-names>D</given-names></name>. <article-title>Severe asthma and fungi: current evidence</article-title>. <source>Medical mycology</source>. <year>2011</year>;<volume>49</volume>
<issue>Suppl 1</issue>:<fpage>S150</fpage>&#x02013;<lpage>7</lpage>. Epub 2010/07/29. <pub-id pub-id-type="doi">10.3109/13693786.2010.504752</pub-id> .<?supplied-pmid 20662637?><pub-id pub-id-type="pmid">20662637</pub-id></mixed-citation></ref><ref id="pone.0201233.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Matsuwaki</surname><given-names>Y</given-names></name>, <name><surname>Wada</surname><given-names>K</given-names></name>, <name><surname>Moriyama</surname><given-names>H</given-names></name>, <name><surname>Kita</surname><given-names>H</given-names></name>. <article-title>Human eosinophil innate response to Alternaria fungus through protease-activated receptor-2</article-title>. <source>International archives of allergy and immunology</source>. <year>2011</year>;<volume>155</volume>
<issue>Suppl 1</issue>:<fpage>123</fpage>&#x02013;<lpage>8</lpage>. Epub 2011/06/10. <pub-id pub-id-type="doi">10.1159/000327498</pub-id> .<?supplied-pmid 21646807?><pub-id pub-id-type="pmid">21646807</pub-id></mixed-citation></ref><ref id="pone.0201233.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>van de Veerdonk</surname><given-names>FL</given-names></name>, <name><surname>Kullberg</surname><given-names>BJ</given-names></name>, <name><surname>van der Meer</surname><given-names>JW</given-names></name>, <name><surname>Gow</surname><given-names>NA</given-names></name>, <name><surname>Netea</surname><given-names>MG</given-names></name>. <article-title>Host-microbe interactions: innate pattern recognition of fungal pathogens</article-title>. <source>Current opinion in microbiology</source>. <year>2008</year>;<volume>11</volume>(<issue>4</issue>):<fpage>305</fpage>&#x02013;<lpage>12</lpage>. Epub 2008/07/08. <pub-id pub-id-type="doi">10.1016/j.mib.2008.06.002</pub-id> .<?supplied-pmid 18602019?><pub-id pub-id-type="pmid">18602019</pub-id></mixed-citation></ref><ref id="pone.0201233.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>HS</given-names></name>, <name><surname>Kim</surname><given-names>SR</given-names></name>, <name><surname>Kim</surname><given-names>JO</given-names></name>, <name><surname>Lee</surname><given-names>YC</given-names></name>. <article-title>The roles of phytochemicals in bronchial asthma</article-title>. <source>Molecules</source>. <year>2010</year>;<volume>15</volume>(<issue>10</issue>):<fpage>6810</fpage>&#x02013;<lpage>34</lpage>. <source>Epub 2010</source>/10/07. <pub-id pub-id-type="doi">10.3390/molecules15106810</pub-id> .<?supplied-pmid 20924320?><pub-id pub-id-type="pmid">20924320</pub-id></mixed-citation></ref><ref id="pone.0201233.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Reichling</surname><given-names>J</given-names></name>, <name><surname>Schnitzler</surname><given-names>P</given-names></name>, <name><surname>Suschke</surname><given-names>U</given-names></name>, <name><surname>Saller</surname><given-names>R</given-names></name>. <article-title>Essential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties&#x02014;an overview</article-title>. <source>Forschende Komplementarmedizin (2006)</source>. <year>2009</year>;<volume>16</volume>(<issue>2</issue>):<fpage>79</fpage>&#x02013;<lpage>90</lpage>. Epub 2009/05/08. <pub-id pub-id-type="doi">10.1159/000207196</pub-id> .<?supplied-pmid 19420953?><pub-id pub-id-type="pmid">19420953</pub-id></mixed-citation></ref><ref id="pone.0201233.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Marchese</surname><given-names>A</given-names></name>, <name><surname>Orhan</surname><given-names>IE</given-names></name>, <name><surname>Daglia</surname><given-names>M</given-names></name>, <name><surname>Barbieri</surname><given-names>R</given-names></name>, <name><surname>Di Lorenzo</surname><given-names>A</given-names></name>, <name><surname>Nabavi</surname><given-names>SF</given-names></name>, <etal>et al</etal>
<article-title>Antibacterial and antifungal activities of thymol: A brief review of the literature</article-title>. <source>Food chemistry</source>. <year>2016</year>;<volume>210</volume>:<fpage>402</fpage>&#x02013;<lpage>14</lpage>. Epub 2016/05/24. <pub-id pub-id-type="doi">10.1016/j.foodchem.2016.04.111</pub-id> .<?supplied-pmid 27211664?><pub-id pub-id-type="pmid">27211664</pub-id></mixed-citation></ref><ref id="pone.0201233.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>Y</given-names></name>, <name><surname>Jung</surname><given-names>SM</given-names></name>, <name><surname>Yoo</surname><given-names>SA</given-names></name>, <name><surname>Kim</surname><given-names>WU</given-names></name>, <name><surname>Cho</surname><given-names>CS</given-names></name>, <name><surname>Park</surname><given-names>BJ</given-names></name>, <etal>et al</etal>
<article-title>Antinociceptive and anti-inflammatory effects of essential oil extracted from Chamaecyparis obtusa in mice</article-title>. <source>Int Immunopharmacol</source>. <year>2015</year>;<volume>29</volume>(<issue>2</issue>):<fpage>320</fpage>&#x02013;<lpage>5</lpage>. Epub 2015/11/22. <pub-id pub-id-type="doi">10.1016/j.intimp.2015.10.034</pub-id> .<?supplied-pmid 26590113?><pub-id pub-id-type="pmid">26590113</pub-id></mixed-citation></ref><ref id="pone.0201233.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>JK</given-names></name>, <name><surname>Choi</surname><given-names>MS</given-names></name>, <name><surname>Seo</surname><given-names>WT</given-names></name>, <name><surname>Rinker</surname><given-names>DL</given-names></name>, <name><surname>Han</surname><given-names>SW</given-names></name>, <name><surname>Cheong</surname><given-names>GW</given-names></name>. <article-title>Chemical composition and antimicrobial activity of Chamaecyparis obtusa leaf essential oil</article-title>. <source>Fitoterapia</source>. <year>2007</year>;<volume>78</volume>(<issue>2</issue>):<fpage>149</fpage>&#x02013;<lpage>52</lpage>. Epub 2006/12/13. <pub-id pub-id-type="doi">10.1016/j.fitote.2006.09.026</pub-id> .<?supplied-pmid 17161919?><pub-id pub-id-type="pmid">17161919</pub-id></mixed-citation></ref><ref id="pone.0201233.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Joo</surname><given-names>SS</given-names></name>, <name><surname>Yoo</surname><given-names>YM</given-names></name>, <name><surname>Ko</surname><given-names>SH</given-names></name>, <name><surname>Choi</surname><given-names>W</given-names></name>, <name><surname>Park</surname><given-names>MJ</given-names></name>, <name><surname>Kang</surname><given-names>HY</given-names></name>, <etal>et al</etal>
<article-title>Effects of essential oil from Chamaecypris obtusa on the development of atopic dermatitis-like skin lesions and the suppression of Th cytokines</article-title>. <source>Journal of dermatological science</source>. <year>2010</year>;<volume>60</volume>(<issue>2</issue>):<fpage>122</fpage>&#x02013;<lpage>5</lpage>. Epub 2010/09/28. <pub-id pub-id-type="doi">10.1016/j.jdermsci.2010.08.008</pub-id> .<?supplied-pmid 20869850?><pub-id pub-id-type="pmid">20869850</pub-id></mixed-citation></ref><ref id="pone.0201233.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>An</surname><given-names>BS</given-names></name>, <name><surname>Kang</surname><given-names>JH</given-names></name>, <name><surname>Yang</surname><given-names>H</given-names></name>, <name><surname>Jung</surname><given-names>EM</given-names></name>, <name><surname>Kang</surname><given-names>HS</given-names></name>, <name><surname>Choi</surname><given-names>IG</given-names></name>, <etal>et al</etal>
<article-title>Anti-inflammatory effects of essential oils from Chamaecyparis obtusa via the cyclooxygenase-2 pathway in rats</article-title>. <source>Mol Med Rep</source>. <year>2013</year>;<volume>8</volume>(<issue>1</issue>):<fpage>255</fpage>&#x02013;<lpage>9</lpage>. Epub 2013/05/09. <pub-id pub-id-type="doi">10.3892/mmr.2013.1459</pub-id> .<?supplied-pmid 23652412?><pub-id pub-id-type="pmid">23652412</pub-id></mixed-citation></ref><ref id="pone.0201233.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>Y</given-names></name>, <name><surname>Yoo</surname><given-names>SA</given-names></name>, <name><surname>Kim</surname><given-names>WU</given-names></name>, <name><surname>Cho</surname><given-names>CS</given-names></name>, <name><surname>Woo</surname><given-names>JM</given-names></name>, <name><surname>Yoon</surname><given-names>CH</given-names></name>. <article-title>Anti-inflammatory effects of essential oils extracted from Chamaecyparis obtusa on murine models of inflammation and RAW 264.7 cells</article-title>. <source>Mol Med Rep</source>. <year>2016</year>;<volume>13</volume>(<issue>4</issue>):<fpage>3335</fpage>&#x02013;<lpage>41</lpage>. Epub 2016/03/05. <pub-id pub-id-type="doi">10.3892/mmr.2016.4905</pub-id> .<?supplied-pmid 26936418?><pub-id pub-id-type="pmid">26936418</pub-id></mixed-citation></ref><ref id="pone.0201233.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Verhasselt</surname><given-names>V</given-names></name>, <name><surname>Buelens</surname><given-names>C</given-names></name>, <name><surname>Willems</surname><given-names>F</given-names></name>, <name><surname>De Groote</surname><given-names>D</given-names></name>, <name><surname>Haeffner-Cavaillon</surname><given-names>N</given-names></name>, <name><surname>Goldman</surname><given-names>M</given-names></name>. <article-title>Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway</article-title>. <source>Journal of immunology (Baltimore, Md: 1950)</source>. <year>1997</year>;<volume>158</volume>(<issue>6</issue>):<fpage>2919</fpage>&#x02013;<lpage>25</lpage>. Epub 1997/03/15. .<?supplied-pmid 9058830?><pub-id pub-id-type="pmid">9058830</pub-id></mixed-citation></ref><ref id="pone.0201233.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Chou</surname><given-names>ST</given-names></name>, <name><surname>Peng</surname><given-names>HY</given-names></name>, <name><surname>Hsu</surname><given-names>JC</given-names></name>, <name><surname>Lin</surname><given-names>CC</given-names></name>, <name><surname>Shih</surname><given-names>Y</given-names></name>. <article-title>Achillea millefolium L. essential oil inhibits LPS-induced oxidative stress and nitric oxide production in RAW 264.7 Macrophages</article-title>. <source>Int J Mol Sci</source>. <year>2013</year>;<volume>14</volume>(<issue>7</issue>):<fpage>12978</fpage>&#x02013;<lpage>93</lpage>. Epub 2013/06/26. <pub-id pub-id-type="doi">10.3390/ijms140712978</pub-id> ; PubMed Central PMCID: PMCPMC3742169.<?supplied-pmid 23797659?><pub-id pub-id-type="pmid">23797659</pub-id></mixed-citation></ref><ref id="pone.0201233.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Lima</surname><given-names>DK</given-names></name>, <name><surname>Ballico</surname><given-names>LJ</given-names></name>, <name><surname>Rocha Lapa</surname><given-names>F</given-names></name>, <name><surname>Goncalves</surname><given-names>HP</given-names></name>, <name><surname>de Souza</surname><given-names>LM</given-names></name>, <name><surname>Iacomini</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Evaluation of the antinociceptive, anti-inflammatory and gastric antiulcer activities of the essential oil from Piper aleyreanum C.DC in rodents</article-title>. <source>J Ethnopharmacol</source>. <year>2012</year>;<volume>142</volume>(<issue>1</issue>):<fpage>274</fpage>&#x02013;<lpage>82</lpage>. Epub 2012/05/17. <pub-id pub-id-type="doi">10.1016/j.jep.2012.05.016</pub-id> .<?supplied-pmid 22588049?><pub-id pub-id-type="pmid">22588049</pub-id></mixed-citation></ref><ref id="pone.0201233.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Carvalho</surname><given-names>IT</given-names></name>, <name><surname>Estevinho</surname><given-names>BN</given-names></name>, <name><surname>Santos</surname><given-names>L</given-names></name>. <article-title>Application of microencapsulated essential oils in cosmetic and personal healthcare products&#x02014;a review</article-title>. <source>International journal of cosmetic science</source>. <year>2016</year>;<volume>38</volume>(<issue>2</issue>):<fpage>109</fpage>&#x02013;<lpage>19</lpage>. Epub 2015/04/30. <pub-id pub-id-type="doi">10.1111/ics.12232</pub-id> .<?supplied-pmid 25923295?><pub-id pub-id-type="pmid">25923295</pub-id></mixed-citation></ref><ref id="pone.0201233.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Lai</surname><given-names>X</given-names></name>, <name><surname>Sun</surname><given-names>C</given-names></name>, <name><surname>Tian</surname><given-names>H</given-names></name>, <name><surname>Zhao</surname><given-names>W</given-names></name>, <name><surname>Gao</surname><given-names>L</given-names></name>. <article-title>Evaluation of poly(styrene-alt-maleic anhydride)-ethanol as enteric coating material</article-title>. <source>International journal of pharmaceutics</source>. <year>2008</year>;<volume>352</volume>(<issue>1&#x02013;2</issue>):<fpage>66</fpage>&#x02013;<lpage>73</lpage>. Epub 2007/12/07. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2007.10.011</pub-id> .<?supplied-pmid 18054184?><pub-id pub-id-type="pmid">18054184</pub-id></mixed-citation></ref><ref id="pone.0201233.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Guimaraes</surname><given-names>AG</given-names></name>, <name><surname>Quintans</surname><given-names>JS</given-names></name>, <name><surname>Quintans</surname><given-names>LJ</given-names><suffix>Jr</suffix></name>. <article-title>Monoterpenes with analgesic activity&#x02014;a systematic review</article-title>. <source>Phytotherapy research: PTR</source>. <year>2013</year>;<volume>27</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>15</lpage>. Epub 2013/01/09. <pub-id pub-id-type="doi">10.1002/ptr.4686</pub-id> .<?supplied-pmid 23296806?><pub-id pub-id-type="pmid">23296806</pub-id></mixed-citation></ref><ref id="pone.0201233.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Shih</surname><given-names>MF</given-names></name>, <name><surname>Chen</surname><given-names>LY</given-names></name>, <name><surname>Tsai</surname><given-names>PJ</given-names></name>, <name><surname>Cherng</surname><given-names>JY</given-names></name>. <article-title>In vitro and in vivo therapeutics of beta-thujaplicin on LPS-induced inflammation in macrophages and septic shock in mice</article-title>. <source>International journal of immunopathology and pharmacology</source>. <year>2012</year>;<volume>25</volume>(<issue>1</issue>):<fpage>39</fpage>&#x02013;<lpage>48</lpage>. Epub 2012/04/18. <pub-id pub-id-type="doi">10.1177/039463201202500106</pub-id> .<?supplied-pmid 22507316?><pub-id pub-id-type="pmid">22507316</pub-id></mixed-citation></ref><ref id="pone.0201233.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Mohammadi</surname><given-names>A</given-names></name>, <name><surname>Mehrzad</surname><given-names>J</given-names></name>, <name><surname>Mahmoudi</surname><given-names>M</given-names></name>, <name><surname>Schneider</surname><given-names>M</given-names></name>, <name><surname>Haghparast</surname><given-names>A</given-names></name>. <article-title>Effect of culture and maturation on human monocyte-derived dendritic cell surface markers, necrosis and antigen binding</article-title>. <source>Biotechnic &#x00026; histochemistry: official publication of the Biological Stain Commission</source>. <year>2015</year>;<volume>90</volume>(<issue>6</issue>):<fpage>445</fpage>&#x02013;<lpage>52</lpage>. Epub 2015/04/07. <pub-id pub-id-type="doi">10.3109/10520295.2015.1017536</pub-id> .<?supplied-pmid 25842987?><pub-id pub-id-type="pmid">25842987</pub-id></mixed-citation></ref><ref id="pone.0201233.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Gupta</surname><given-names>SK</given-names></name>, <name><surname>Deb</surname><given-names>R</given-names></name>, <name><surname>Gaikwad</surname><given-names>S</given-names></name>, <name><surname>Saravanan</surname><given-names>R</given-names></name>, <name><surname>Mohan</surname><given-names>CM</given-names></name>, <name><surname>Dey</surname><given-names>S</given-names></name>. <article-title>Recombinant flagellin and its cross-talk with lipopolysaccharide&#x02014;effect on pooled chicken peripheral blood mononuclear cells</article-title>. <source>Research in veterinary science</source>. <year>2013</year>;<volume>95</volume>(<issue>3</issue>):<fpage>930</fpage>&#x02013;<lpage>5</lpage>. Epub 2013/08/14. <pub-id pub-id-type="doi">10.1016/j.rvsc.2013.07.015</pub-id> .<?supplied-pmid 23937992?><pub-id pub-id-type="pmid">23937992</pub-id></mixed-citation></ref><ref id="pone.0201233.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Andersson</surname><given-names>M</given-names></name>, <name><surname>Downs</surname><given-names>S</given-names></name>, <name><surname>Mitakakis</surname><given-names>T</given-names></name>, <name><surname>Leuppi</surname><given-names>J</given-names></name>, <name><surname>Marks</surname><given-names>G</given-names></name>. <article-title>Natural exposure to Alternaria spores induces allergic rhinitis symptoms in sensitized children</article-title>. <source>Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology</source>. <year>2003</year>;<volume>14</volume>(<issue>2</issue>):<fpage>100</fpage>&#x02013;<lpage>5</lpage>. Epub 2003/04/05. .<?supplied-pmid 12675755?><pub-id pub-id-type="pmid">12675755</pub-id></mixed-citation></ref><ref id="pone.0201233.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Rincon</surname><given-names>M</given-names></name>, <name><surname>Anguita</surname><given-names>J</given-names></name>, <name><surname>Nakamura</surname><given-names>T</given-names></name>, <name><surname>Fikrig</surname><given-names>E</given-names></name>, <name><surname>Flavell</surname><given-names>RA</given-names></name>. <article-title>Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells</article-title>. <source>The Journal of experimental medicine</source>. <year>1997</year>;<volume>185</volume>(<issue>3</issue>):<fpage>461</fpage>&#x02013;<lpage>9</lpage>. Epub 1997/02/03. ; PubMed Central PMCID: PMCPMC2196041.<?supplied-pmid 9053446?><pub-id pub-id-type="pmid">9053446</pub-id></mixed-citation></ref></ref-list></back></article>